Intuitive Surgical - ISRG Stock Forecast, Price & News

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ISRG shares. Raymond James reduced their target price on shares of Intuitive Surgical from $294.00 to $255.00 in a report on Friday, July 22nd. BTIG Research dropped their price target on Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating on the stock in a research note on Monday, July 18th. Truist Financial dropped their price target on Intuitive Surgical from $270.00 to $255.00 and set a "buy" rating on the stock in a research note on Friday, July 22nd. Morgan Stanley dropped their price target on Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a research note on Friday, July 15th. Finally, Citigroup dropped their price target on Intuitive Surgical from $360.00 to $305.00 in a research note on Tuesday, May 17th. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $273.23.

Intuitive Surgical Trading Up 1.0 %

Intuitive Surgical stock traded up $2.35 during mid-day trading on Friday, hitting $238.37. The company had a trading volume of 1,741,868 shares, compared to its average volume of 2,139,600. Intuitive Surgical has a 12-month low of $186.83 and a 12-month high of $369.69. The company's fifty day moving average is $213.46 and its 200-day moving average is $248.59. The company has a market capitalization of $85.12 billion, a price-to-earnings ratio of 59.76, a P/E/G ratio of 6.63 and a beta of 1.29.

Intuitive Surgical (NASDAQ:ISRG - Get Rating) last released its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $1.14 EPS for the quarter, topping the consensus estimate of $1.01 by $0.13. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same period last year, the firm posted $1.42 EPS. As a group, sell-side analysts expect that Intuitive Surgical will post 3.76 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Gary S. Guthart sold 79,412 shares of the company's stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the completion of the transaction, the chief executive officer now directly owns 54,607 shares of the company's stock, valued at approximately $11,811,494.10. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, EVP Myriam Curet sold 9,000 shares of the company's stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares of the company's stock, valued at approximately $48,825. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Gary S. Guthart sold 79,412 shares of the company's stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $216.30, for a total value of $17,176,815.60. Following the transaction, the chief executive officer now directly owns 54,607 shares of the company's stock, valued at $11,811,494.10. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 94,787 shares of company stock worth $20,719,321. Corporate insiders own 0.90% of the company's stock.